Accelerate Your Success with Leading Preclinical CROs: Accelevir and Noble Life Sciences

The Power of Partnership: Expertly Navigating the Complexities of Preclinical Research Services.

At Accelevir, we bring unparalleled expertise and innovative assay technologies to the forefront of preclinical research. Our strategic partnership with Noble Life Sciences enhances our ability to deliver precise, reliable, and actionable data across critical therapeutic areas, including oncology, infectious diseases, and diabetes. Together, we offer a comprehensive suite of preclinical research services designed to propel your projects forward, from concept to clinical trials. We specialize in many disease areas, including cell and gene therapies, infectious diseases, virology, oncology, diabetes, and more.

Bring Your Therapeutic Innovations to Life With Leading Preclinical CROs

Extensive and Customized Solutions Tailored to Your Project

In vivo Efficacy Studies
Immune Response Profiling
- Flow Cytometry
- ELISpot/FluoroSpot
- Cell Proliferation and Cytotoxicity Assays
- Cytokine/Chemokine Profiling
In vitroAssays
Ultrasensitive Molecular Testing
- Multiplex dPCR
- Viral Genome Sequencing
- Vector Characterization and Monitoring
Pharmacokinetics and Toxicology
Cell Processing and Subset Enrichment
Biomarker Development and Validation
IND Enabling Studies

Offering comprehensive support throughout your research journey is important to us. From initial study design to final data interpretation, our preclinical research services provide full-spectrum assistance, ensuring that your project is meticulously planned and executed. With our integrated approach and state-of-the-art technologies, you can trust that your therapeutic development is in expert hands, setting the stage for successful clinical outcomes.

With Accelevir and Noble Life Sciences, you’ll achieve precise, reliable, and actionable data to propel your research forward.

Accelevir’s strategic partnership with Noble Life Sciences combines our expertise in virology and pharmacology with Noble’s advanced research facilities and technical capabilities. Together, our suite of preclinical services is designed to meet the most challenging research and development needs.

Our advanced molecular and cellular assays, central to our preclinical research services, deliver insights into the biological effects of experimental treatments.

Turning Data into Actionable Insights

Our team stands ready to analyze and interpret your data, ensuring you gain meaningful conclusions about the efficacy and safety of your treatments. We offer detailed statistical analysis and bioinformatics, along with integrative consultations that enhance your understanding of the biological mechanisms involved. As top-tier preclinical CROs, we streamline your development process, reducing both time and cost, and accelerating your path from discovery to clinical trials.

Why Choose Accelevir and Noble Life Sciences?

Discover the Difference

Partnering with Accelevir and Noble Life Sciences gives you access to advanced, cutting-edge assays and innovative preclinical research services specifically customized to meet your project needs.

Unmatched Expertise and Innovation

Enhanced Precision and Reliability

Streamlined Development Process

Comprehensive Support

About Noble Life Sciences

Noble Life Sciences is a leading preclinical contract research organization (CRO) specializing in oncology, infectious diseases, and diabetes research. They offer comprehensive preclinical research services, including study design, specimen collection, molecular and cellular assays, data analysis, and regulatory reporting.

Noble Life Sciences partners with Accelevir Diagnostics to provide cutting-edge assay technologies and innovative solutions, ensuring precise and reliable data. Their integrated approach accelerates therapeutic development, helping clients move efficiently from discovery to clinical trials.

Unlock the full potential of your preclinical research with Accelevir and Noble Life Sciences. Contact us today to explore how our preclinical research services can support your journey from discovery to cure. We look forward to hearing from you.

Contact our team